NCT06287749
- Conditions
- CtDNA, Liquid Biopsy, Minimal Residual Disease, +7 more
- Locations
-
- CHU de Montpellier Montpellier, Hérault, France
Clinical trial condition
Neoplasm, Residual
Explore clinical trials studying Neoplasm, Residual. Study availability and eligibility vary by location and protocol.
207 public trials
79 recruiting studies
Neoplasm, Residual trial results
NCT05196087
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +18 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
NCT07021677
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
- Locations
-
- Dr.Sumeet Mirgh Navi Mumbai, Maharashtra, India
NCT06414148
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
- Westmead Hospital Westmead, New South Wales, Australia
- Royal Brisbane and Women's Hospital Herston, Queensland, Australia
- Alfred Hospital Melbourne, Victoria, Australia
Recruiting
Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for MRD-Positive B-ALL Patients in CR1
NCT06718244
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China
NCT06963307
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
- Locations
-
- Sheba Medical Center Ramat Gan, Israel
NCT05959720
- Conditions
- Acute Lymphoid Leukemia, Chemotherapeutic Toxicity, Gene Abnormality, +16 more
- Locations
-
- Instituto do Cancer do Estado de Sao Paulo São Paulo, Brazil
NCT06930807
- Conditions
- Adaptive Treatment, Bronchial Neoplasms, Carcinoma, Bronchogenic, +14 more
- Locations
-
- Peking University People's Hospital Beijing, Beijing Municipality, China
Recruiting
Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Stage III NSCLC
NCT06111807
- Conditions
- Disease Attributes, Disease Progression, Hypersensitivity, +14 more
- Locations
-
- Centre Hospitalier Universitaire de Nice Nice, France
- Antoine Lacassagne Center Nice, France
- Department of thoracic oncology- LungenClinic Großhansdorf Großhansdorf, Grosshansdorf, Germany
- Isala Zwolle, Overijssel, Netherlands
NCT06886074
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
- Locations
-
- Hospital Universitario Dr. Jose E. Gonzalez Monterrey, Nuevo León, Mexico